a collage image of arm affected by psoriasis and molecular structure of Icotrokinra

Article

PDF: Icotrokinra: A Promising Oral IL-23 Receptor Inhibitor for Moderate-to-Severe Plaque Psoriasis

Name: PDF: Icotrokinra: A Promising Oral IL-23 Receptor Inhibitor for Moderate-to-Severe Plaque Psoriasis
Price: 1.99 USD
Availability: InStock

$1.99

PDF Download: Discover icotrokinra, a groundbreaking oral peptide that targets the IL-23 receptor to treat moderate-to-severe plaque psoriasis. Clinical trials show it delivers biologic-like skin clearance in a convenient once-daily pill.
Read online:
Icotrokinra: A Promising Oral IL-23 Receptor Inhibitor for Moderate-to-Severe Plaque Psoriasis

Category: Dermatology

PDF: Icotrokinra: A Promising Oral IL-23 Receptor Inhibitor for Moderate-to-Severe Plaque Psoriasis

Related products

Purchase whole issue (PDF): Jul-Aug 2017

Purchase whole issue (PDF): May-Jun 2017

Purchase whole issue (PDF): May-Jun 2016

Purchase whole issue (PDF): Nov-Dec 2017